C3: Improving Manufacturing via Modern Technology

Tuesday, September 28, 2021

15:30 – 17:00 EDT

Moderator(s)

Rebecca Dombrowski, MS

Supervisory Investigator, ORA
U.S. FDA
Detroit, Michigan, United States

Carl-Helmut Coulon, PhD

Head of Future Manufacturing Concepts
INVITE GmbH
Cologne, Nordrhein-Westfalen, Germany
James Weber

Advisor IT - Digital Manufacturing
Eli Lilly and Company
Indianapolis, Indiana, United States
David Wolton

Engineering Technology Lead
Takeda
zurich, Zurich, Switzerland

Nicholas Violand

Investigator/Drug National Expert, ORA
U.S. FDA
Woodland Hills, California, United States

15:30 – 15:50 EDT

Robotics and BIometrics Initiatives in Drug Product Manufacturing
Presenter: James C. Weber – Eli Lilly and Company
15:50 – 16:03 EDT

Facilitating Deployment of Autonomous Mobile Robotics (AMRs)
Presenter: Carl-Helmut Coulon, PhD – INVITE GmbH
Presenter: David Wolton – Takeda
16:03 – 16:24 EDT

Considerations for Adopting Modern Technologies
Regulatory Presenter: Nicholas A. Violand – U.S. FDA
16:24 – 17:00 EDT

Live Q&A (C3)
Moderator: Rebecca E. Dombrowski, MS – U.S. FDA
Panelist: Carl-Helmut Coulon, PhD – INVITE GmbH
Panelist: James C. Weber – Eli Lilly and Company
Panelist: David Wolton – Takeda
Regulatory Panelist: Nicholas A. Violand – U.S. FDA